Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer

Title
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
Authors
Keywords
BRCA2, Circulating tumor DNA, Cell-free DNA, Liquid biopsy, Enzalutamide, Abiraterone, Castration-resistant prostate cancer, DNA repair
Journal
EUROPEAN UROLOGY
Volume 72, Issue 1, Pages 34-42
Publisher
Elsevier BV
Online
2017-03-02
DOI
10.1016/j.eururo.2017.02.023

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started